Biogen, UCB Take A Leap In Lupus With Promising Phase 3 Results

All NewsJune 12, 2025

UCB and Biogen’s lupus candidate showed strong Phase 3 results, including fatigue improvement and higher remission versus standard care.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent